US4572837A - Protein product - Google Patents
Protein product Download PDFInfo
- Publication number
- US4572837A US4572837A US06/625,646 US62564684A US4572837A US 4572837 A US4572837 A US 4572837A US 62564684 A US62564684 A US 62564684A US 4572837 A US4572837 A US 4572837A
- Authority
- US
- United States
- Prior art keywords
- protein
- acidic
- concentration
- clupeine
- edible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004169 proteins and genes Human genes 0.000 title claims description 58
- 108090000623 proteins and genes Proteins 0.000 title claims description 58
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims abstract description 46
- 101800000263 Acidic protein Proteins 0.000 claims abstract description 44
- 239000000839 emulsion Substances 0.000 claims abstract description 16
- 239000006185 dispersion Substances 0.000 claims abstract 17
- 108010040512 Clupeine Proteins 0.000 claims description 70
- 239000006260 foam Substances 0.000 claims description 56
- 102000016943 Muramidase Human genes 0.000 claims description 16
- 108010014251 Muramidase Proteins 0.000 claims description 16
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 16
- 229960000274 lysozyme Drugs 0.000 claims description 16
- 235000010335 lysozyme Nutrition 0.000 claims description 16
- 239000004325 lysozyme Substances 0.000 claims description 16
- 235000000346 sugar Nutrition 0.000 claims description 13
- 150000001875 compounds Chemical group 0.000 claims description 12
- 150000002632 lipids Chemical class 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 6
- 230000000269 nucleophilic effect Effects 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 108010088751 Albumins Proteins 0.000 claims description 4
- 102000009027 Albumins Human genes 0.000 claims description 4
- 108050004114 Monellin Proteins 0.000 claims description 3
- 150000001718 carbodiimides Chemical class 0.000 claims description 3
- 239000000892 thaumatin Substances 0.000 claims description 3
- 235000010436 thaumatin Nutrition 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 239000012071 phase Substances 0.000 claims 1
- 238000005187 foaming Methods 0.000 abstract description 14
- 230000002378 acidificating effect Effects 0.000 abstract description 8
- 235000015145 nougat Nutrition 0.000 abstract description 5
- 239000000243 solution Substances 0.000 description 60
- 235000018102 proteins Nutrition 0.000 description 55
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 36
- 229940098773 bovine serum albumin Drugs 0.000 description 35
- 235000013601 eggs Nutrition 0.000 description 33
- 229930006000 Sucrose Natural products 0.000 description 25
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 25
- 239000005720 sucrose Substances 0.000 description 25
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 20
- 239000012460 protein solution Substances 0.000 description 20
- 239000000499 gel Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 108010058846 Ovalbumin Proteins 0.000 description 16
- 229940092253 ovalbumin Drugs 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 239000003925 fat Substances 0.000 description 13
- 210000002381 plasma Anatomy 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 12
- 239000000470 constituent Substances 0.000 description 11
- 102000035118 modified proteins Human genes 0.000 description 11
- 108091005573 modified proteins Proteins 0.000 description 11
- 102000007544 Whey Proteins Human genes 0.000 description 10
- 108010046377 Whey Proteins Proteins 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000001879 gelation Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000021119 whey protein Nutrition 0.000 description 6
- 108010060630 Lactoglobulins Proteins 0.000 description 5
- 102000008192 Lactoglobulins Human genes 0.000 description 5
- 244000299461 Theobroma cacao Species 0.000 description 5
- 235000009470 Theobroma cacao Nutrition 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000020303 café frappé Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- KQSSATDQUYCRGS-UHFFFAOYSA-N methyl glycinate Chemical group COC(=O)CN KQSSATDQUYCRGS-UHFFFAOYSA-N 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- ZDLDXNCMJBOYJV-YFKPBYRVSA-N L-arginine, methyl ester Chemical compound COC(=O)[C@@H](N)CCCN=C(N)N ZDLDXNCMJBOYJV-YFKPBYRVSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000002569 water oil cream Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 101000889976 Arabidopsis thaliana Myb family transcription factor APL Proteins 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- -1 amino acid ester Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 239000012888 bovine serum Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 2
- 102000034238 globular proteins Human genes 0.000 description 2
- 108091005896 globular proteins Proteins 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 150000002337 glycosamines Chemical class 0.000 description 2
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010026206 Conalbumin Proteins 0.000 description 1
- 208000035859 Drug effect increased Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- VPKDCDLSJZCGKE-UHFFFAOYSA-N carbodiimide group Chemical group N=C=N VPKDCDLSJZCGKE-UHFFFAOYSA-N 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D13/00—Finished or partly finished bakery products
- A21D13/50—Solidified foamed products, e.g. meringues
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
- A23G3/52—Aerated, foamed, cellular or porous products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
- A23P30/40—Foaming or whipping
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/804—Low calorie, low sodium or hypoallergic
Definitions
- This invention relates to aqueous solutions containing proteins which are capable of forming foams, gels and/or emulsions.
- Protein foams may be obtained by whipping an aqueous solution of a protein.
- the whipping process comprises agitating the solution in the presence of air so that a foam consisting of air cells surrounded by the solution is formed.
- the function of the protein in these foams is to form a cohesive film or skin around the air cells to prevent the foam collapsing when whipping is stopped.
- the solution may contain other constituents such as sugar.
- foams are used for a variety of culinary purposes, such as the making of meringues in which the protein foam containing sugar is baked to produce a mass of air cells enclosed by solid walls of protein and sugar.
- the protein solution is commonly obtained from white of egg but many other sources of protein may be used.
- the foam-forming capacity of a protein solution as measured by the increase in volume of the solution on whipping, and also the stability on standing of the foam depends in part on the identity of the protein used. For example a solution of egg albumen gives a reasonable degree of expansion on whipping and the foam formed may be stored for a considerable time before collapsing but a solution of ovalbumin or ovotransferrin without other dissolved constituents gives very limited expansion and poor foam stability.
- the expansion on whipping and stability of the foam are affected by other constituents dissolved or dispersed in the protein solution.
- sucrose may increase both expansion on whipping and foam stability but the presence of even small quantities of lipids such as vegetable oils and fats generally suppresses foam formation either partially or completely. It has therefore been difficult to provide a satisfactory protein foam containing oils or fats and when making a protein foam it has been essential to avoid contamination of the solution by lipids, including contamination by yolk of egg.
- Aqueous solutions of proteins may also be used to form protein gels which are a constituent of many manufactured foodstuffs.
- a protein solution may be converted to a gel on heating but a minimum concentration of protein in the solution is generally required to obtain a firm gel.
- the minimum concentration for gelling is about 5 g/100 ml.
- Aqueous protein solutions i.e., solutions containing globular proteins
- Such emulsions are used in manufactured foodstuffs such as mayonnaises and sauces. It is generally desirable that such emulsions should be stable on storage for long periods, however it is found that solutions of many proteins give emulsions which separate on storage for quite short periods.
- the proteins used in culinary applications are normally acidic proteins, that is they have isoelectric points less than 7.
- the acidic proteins include globular proteins, especially albumins such as ovalbumin, bovine serum albumin, bovine plasma, whey protein isolates and hydrolysed soya isolates.
- an aqueous solution containing at lest one acidic protein and at least one basic protein dissolved therein.
- an acidic protein is one having an isoelectric point of less than 7 and a basic protein is one having an isoelectric point above 7.
- the isoelectric point of the basic protein is preferably at least 9.5.
- the molecular weight of the basic protein is preferably at least 1000 and it may be of the order of 4,500-5,000 or higher.
- Examples of basic proteins which may be used are clupeine, lysozyme, thaumatin and monellin.
- the acidic protein may be obtained from a wide variety of sources including milk, eggs, blood plasma, legumes, meat and microorganisms.
- the pH value of the solution should be such that the acidic protein and the basic protein carry opposite electric charges.
- a pH value of the order of 5 to 8 is generally suitable.
- the basic proteins clupeine and lysozyme have isoelectric points in excess of 10 and the acidic proteins ovalbumin and bovine serum albumin have isoelectric points of about 4.6 so that at pH 7-8 these types of protein carry opposite charges.
- the scope of the invention is not to be limited by theoretical considerations it is believed that the presence in the solution of proteins having opposite electric charges has the effect of stabilizing and strengthening the walls surrounding the air cells when the solution is whipped into a foam, as well as forming a stronger gel on heating and increasing the stability of an emulsion formed from the solution.
- the level of acidic protein required in the solution depends upon the application.
- a concentration of 0.5 g/100 ml or more in the solution is generally suitable for forming a foam.
- the amount of basic protein required to achieve improved foaming is normally less than that of the acidic protein.
- a ratio of acidic to basic protein from 100 to 1 to 5 to 1 on a weight basis is usually suitable, the improvement in foam behaviour increasing with the amount of basic protein. It has been found that increasing the amount of basic protein above about 0.05 g/ml gives no further improvement in foaming behaviour when the concentration of acidic protein is 0.5 g/100 ml.
- the solution may contain dissolved compounds other than proteins and these compounds may have a synergistic effect in further improving the degree of foaming and foam stability of the solution.
- Synergistic compounds include compounds which can form hydrogen bonds, such as sugars (for example sucrose) and glycerol and also compounds which reduce the surface tension of the solution, such as ethanediol, ethanediol dimethyl ether and dioxan.
- the hydrogen bonding synergistic compounds typically have a marked effect on foaming behaviour at concentrations of the order of 1-20 g/100 ml but compounds which reduce the surface tension show synergistic activity at much lower concentrations, for example 0.5 g/100 ml.
- Another food product is nougat, obtained by beating a mixture of a protein solution and a sugar syrup to aerate the mixture followed by addition of further syrup and fat.
- the use of a protein solution according to the invention allows a nougat of satisfactory density to be obtained using a much smaller amount of protein.
- a solution of a protein requires a protein concentration which is above a minimum and for many acidic proteins this minimum concentration is of the order of 5% by weight. This minimum concentration is greatly reduced when a basic protein is present and even when the protein concentration is above that required to give a gel in the absence of basic protein, the addition of basic protein gives a gel of increased strength. Good results are obtained when the weight of basic protein present is at least 10% of the weight of acidic protein although improved gelling behaviour may be obtained with a lower content of basic protein.
- a solution of an acidic protein will form a gel on heating for 10 minutes at 100° C. only at a protein concentration of at least 5% by weight but the presence of a basic protein in the solution, in an amount of 10% of the weight of acidic protein, allows a gel to form at a protein concentration of only 1.5% by weight.
- the basic protein used in the present invention may be obtained by modifying an acidic protein to increase its isoelectric point so that it becomes a basic protein.
- the acidic protein may be modified to neutralize at least some of the acidic, negatively charged amino acid residues of the protein by attaching a nucleophilic group to the carboxyl group, thus increasing the isoelectric point.
- the nucleophilic group may contain basic nitrogen and be attached by means of an amide linkage.
- the group may be provided by a neutral or basic amino acid ester, an aminosugar or ammonium ion.
- One method of attaching the nucleophilic group to the carboxyl group comprises reacting the protein with a carbodi-imide and causing the adduct so formed to react with a nucleophilic reagent to displace the carbodi-imide group.
- the reaction is shown in the following scheme: ##STR1##
- RCO 2 H is the acidic protein
- R 1 and R 2 may be hydrogen or organic groups and X is the nucleophilic group.
- the carbodi-imide may be 1-ethyl-3-dimethylaminopropyl carbodi-imide (EDC)
- reagent HX may be an amino acid ester such as glycine methyl or ethyl ester or arginine methyl ester, an aminosugar such as glucosamine or ammonium ion.
- the acidic protein may be a readily available protein such as ⁇ -lactoglobulin, ovalbumin, bovine serum albumin, soya protein and whey isolate.
- the reaction may generally be performed in aqueous solution at a pH from 4.0 to 7.5 and at or near ambient temperature.
- the pH may be adjusted as necessary during the reaction by addition of acid. Under these mild reaction conditions the protein does not become denatured.
- the modified protein may be recovered by dialysis and freeze-dried for storage.
- the basic proteins so obtained may be used in the same way as the natural basic proteins, with the same beneficial results.
- An acidic commercial whey protein isolate was dissolved in water to a concentration of 2.0% W/W.
- the pH of the solution was adjusted to pH 6.0 with hydrochloric acid (0.5M) and glycine ethyl ester was added to a concentration of 5.0% W/W.
- EDC was added to a concentration of 0.6% W/W and the mixture held at 40° C. for 8 hours.
- the reaction was stopped by adjusting the pH 3.0 with glacial acetic acid.
- the reaction mixture was then dialysed against running tap water for 48 hours and the retentate freeze-dried to produce a modified (basic) protein isolate (M.P.I.).
- Amino acid analysis of the modified protein thus produced showed that 25% of the carboxyl groups of the original protein had been modified.
- the isoelectric points of the modified proteins were predominantly higher than pH 9.5, whereas the original whey protein isolate comprised proteins having isoelectric points of about 5.
- the acidic protein ⁇ -lactoglobulin was dissolved in water to a concentration of 1.3% weight/weight.
- the pH of the solution was adjusted to 4.75 and glycine methyl ester was added to a concentration of 1.33M.
- EDC was added to a concentration of 0.40M and the mixture was held at 25° C. for 1 hour, the pH being maintained at 4.75 by addition of 0.5M hydrochloric acid as required.
- the product was then dialysed against water for 48 hours and the retentate was freeze-dried to produce a modified protein.
- Aminoacid analysis of the modified protein thus produced showed that 74% of the carboxyl groups of the original protein had been modified.
- the isoelectric point of the modified protein was higher than pH 10, whereas that of the original ⁇ -lactoglobulin was pH 5.
- Example 2 The procedure of Example 2 was repeated except that bovine serum albumin was used instead of ⁇ -lactoglobulin.
- the isoelectric point of the modified protein so produced was again greater than pH 10.
- Example 2 The procedure of Example 2 was repeated except that in different trials the glycine methyl ester was replaced by equivalent molar amounts of glycine ethyl ester, glucosamine, ammonium chloride and arginine methyl ester. In all cases the isoelectric point of the modified protein produced exceeded pH 10.
- Example 2 The procedure of Example 2 was followed but replacing ⁇ -lactoglobulin with a purified whey isolate and glycine methyl ester with arginine methyl ester.
- the isoelectric point of the modified protein produced was greater than 10.
- % foam expansion (FE) and % foam liquid stability (FLS) were calculated as follows: ##EQU1##
- the first and second columns give the result obtained with a solution containing 0.5% of an acidic protein alone, the third and fourth columns with the same solutions but containing 0.05% of clupeine, and the fifth to eight columns with the same solutions containing 10% of sucrose.
- the pH value of all the solutions was 7.
- Example 6 The procedure of Example 6 was followed using solutions containing 0.5% of ovalbumin with or without 0.05% of clupeine and with the additional constituents given in Table 3.
- the pH value of the solutions was 8. It can be seen from Table 3 that the hydrogen-bonding compounds sucrose and glycerol and also the surface tension-reducing compound ethanediol had a marked synergistic effect on the foaming behaviour of the solutions.
- Example 6 In order to investigate the effect of differing amounts of clupeine the procedure of Example 6 was followed using solutions of pH 8 containing 0.5% of ovalbumin and 10% sucrose with the concentrations of clupeine shown in Table 4 present. The results show that the clupeine had a marked effect even in amounts of 0.005% and the effect increased at higher clupeine amounts. No further improvement was found with concentrations of clupeine above 0.05%.
- Example 6 The procedure of Example 6 was followed except that 0.1% of lysozyme was used instead of clupeine. The results are shown in Table 5. These results show that lysozyme has a similar effect as clupeine with and without sucrose present.
- Example 6 The procedure of Example 6 was followed but using solutions of pH 8 containing 0.5% of bovine serum albumin together with the constituents given in Table 6. It will be noted that in all cases the presence of clupeine gave a large improvement in foaming behaviour.
- Example 6 The procedure of Example 6 was followed but using the constituents shown in Table 7.
- the oil used was Mazola vegetable oil and the pH value of the protein solution was 6.
- the results are shown in Table 7. It can be seen that 1.0% of oil destroyed the whipping properties of the BSA (bovine serum albumin) solution but 10% of oil had little effect on the properties of the BSA/clupeine solution. Large amounts of oil, for example 25%, reduced the foam expansion of the BSA/clupeine system somewhat but increased the foam stability.
- the solutions described above may be foamed in order to produce foamed culinary products of kinds which are already known, such as meringues, cakes mixes and batters. They may also be used in aerated food products which contain lipids, such as low calory dietary foods, which have not hitherto been made by a foaming process. Foams made from the protein solutions may also be used for non-culinary purposes, for example as aerated lubricants.
- Nougat consists of a frappe of egg white and glucose syrup to which a sugar syrup, fat and sugar to grain are added.
- the standard recipe is as follows:
- Ingredients 1 were mixed and left to soak for at least two hours. 1 and 2 were then beaten to a stiff foam in a Hobart CE100 mixer for 5 minutes on speed (3). The density of the frappe was measured. Meanwhile ingredients 3 were mixed, dispersed over a flame for 1 min, then boiled to 270° F. The resultant syrup was slowly poured into the frappe in a thin stream, while mixing on speed (1). The icing sugar and lastly the melted fat were mixed in on speed (1) and the density of the mixture was measured. The remainder of the mixture was poured into trays lined with rice paper and allowed to grain overnight.
- MPI is a modified protein isolate made by the method of Example 1.
- Standard recipe 150 g protein solutions (pH 7.5), 300 g caster sugar.
- a Simon Reels Oven was set at 115° C. Protein solutions were beaten for 6 minutes at top speed in a 5-liter capacity bowl using a Hobart CE 100 mixer fitted with a whisk. Half the caster sugar was added gradually with the mixer at slow speed and then the mix was beaten at top speed for a further 2 minutes. The remaining sugar was gently folded into the mix using a wooden spoon. The mix was poured into a savoy bag and shells were piped out on a metal sheet covered with aluminium foil. The shells were baked for 60 minutes until the outer parts were firmly set. Holes were made in the bases and the meringues dried overnight in a warm oven (balmic at 30° C.).
- the densities (g/100 ml) of the meringue mixes and meringues after drying were measured.
- the amount of a protein powder required to give a solution of the desired concentration was calculated from its protein content (nitrogen ⁇ factor). Distilled water was stirred vigorously with a magnetic stirrer, creating a vortex, and the powdered protein added slowly. Stirring was continued at a reduced speed for 20 minutes. In the case of plasma, the resulting solution was allowed to stand for one hour to allow the insoluble proteins to settle and the upper soluble layer was decanted off (the amount of insoluble protein was compensated for). All the other protein solutions were used direct.
- Solutions containing 1 g/100 ml of egg albumen in water and 1 g/100 ml plasma protein in water were prepared.
- the solutions had a pH value of 6.
- To samples of these solutions were added 0.16 g/100 ml solution of lysozyme.
- the solutions were emulsified with equal weights of corn oil by simultaneously pouring the solutions and oil into one side of an ultrasonicator (Minisonic 4 of Ultrasonic Ltd.). The mixture as allowed to circulate through the apparatus for 30 seconds, collected and recirculated through the ultrasonicator four times more.
- the resulting emulsions were allowed to stand undisturbed for one week in the dark. The percentages of oil and water separation were then measured.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Description
______________________________________
Ingredient g
______________________________________
Spray dried egg albumen
15
1
Water 30
Liquid glucose 42DE 125 2
Sucrose 760
Liquid glucose 42DE 525 3
Water 190
Icing sugar 35 4
(Hydrogenated palm kernel oil)
45
______________________________________
TABLE I
______________________________________
Effect of clupeine with and without sucrose
on protein foam expansion and stability
Distilled Water
10% Sucrose
Protein + Protein +
alone Clupeine alone Clupeine
Protein FE FLS FE FLS FE FLS FE FLS
______________________________________
Egg albumen
240 19 160 16 440 35 810 76
Ovalbumin
40 10 40 10 120 10 620 23
Bovine serum
340 12 680 54 460 10 800 71
albumin
Bovine plas-
260 12 360 30 320 28 800 73
ma
Whey protein
600 23 780 33 620 19 840 48
isolate
Soy isolate
500 10 720 68 480 20 760 74
(enzyme
hydrolysed)
______________________________________
TABLE 2
______________________________________
Effect of clupeine on protein
foaming systems containing oil
Comments on
Constituents FE % FLS % Foam
______________________________________
0.5% BSA, 10% sucrose
460 10 pourable
0.5% BSA, 10% sucrose
0 0 no foam
1% oil
0.5% BSA, 10% sucrose
720 64 stiff
1% oil, 0.05% clupeine
1% BSA, 10% sucrose, 5% oil
60 0 no foam
1% BSA, 10% sucrose, 5% oil,
800 81 very good; stiff
0.1% clupeine
0.5% Whey, 10% sucrose
260 5 poor foam
0.5% Whey, 10% sucrose
660 35 good foam
0.05% clupeine
______________________________________
TABLE 3
______________________________________
Effect of hydrogen bonding compounds
and surface tension reducing compounds
on protein foam expansion stability
System FE % FLS % Comments on Foam
______________________________________
Ovalbumin 40 5 very poor
Ovalbumin + clupeine
40 5 very poor
Ovalbumin + clupeine +
620 22.5 very stiff
10% sucrose
Ovalbumin + clupeine +
620 29.5 very stiff
10% glycerol
Ovalbumin + 0.5%
40 2 very poor
ethanediol
Ovalbumin + clupeine +
560 26 stiff
0.5% ethanediol
______________________________________
TABLE 4
______________________________________
Effect of increasing clupeine concentration on foam expansion
and foam stability of protein sucrose system*
Clupeine Concentration
FE % FLS %
______________________________________
0 40 5
0.005% 300 16
0.010% 520 55
0.015% 700 66
0.025% 720 71
0.05% 640 83
______________________________________
*All systems contained 10% sucrose + 0.5% ovalbumin
TABLE 5
______________________________________
Effect of lysozyme on protein foam expansion
and stability in the presence and absence of sucrose
Distilled water
10% Sucrose
Protein + Protein +
alone Lysozyme alone Lysozyme
Protein FE FLS FE FLS FE FLS FE FLS
______________________________________
Bovine serum
280 12 760 69 360 4 880 85
albumin
Whey protein
600 21 780 47 620 19 840 69
isolate
Egg albumen
240 24 220 26 440 35 800 90
Ovalbumin
40 10 40 10 120 10 760 54
Ovotrans-
100 5 100 5 140 7 420 23
ferrin.sup.!
Bovine plas-
260 12 360 24 300 14 760 70
ma
Bovine β-
200 5 700 40 NT NT NT NT
globulin
Fibrinogen
360 12 80 10 360 31 620 52
Sodium 460 14 540 28 320 17 540 23.5
caseinate
β-Lacto-
480 12 680 88 NT NT NT NT
globulin
______________________________________
.sup.! 0.2% solutions used
NT = not tested
TABLE 6
______________________________________
Effect of clupeine on protein foam expansion
and stability in the presence of liquid materials
FE % FLS % Comments
______________________________________
Glycerol Monostearate (monoglyceride) (GMS)
BSA = 0.5%; pH = 8
BSA + 0.1% GMS only
0 0 no foam
BSA + 0.1% GMS 520 40 reasonable foam
+ 0.05 clupeine
Stearic Acid (Free Fatty Acid)
BSA = 0.5% pH = 8 sucrose = 10%
BSA + 0.1 stearic acid
100 2 poor foam
BSA + 0.1 stearic acid
760 74 very good foam
+ 0.05 clupeine
Lecithin (phospholipid)
BSA = 0.5% pH = 8 sucrose = 10%
0.02% lecithin 0 0 no foam
0.02% lecithin 680 45 good foam
+ 0.02% clupeine
______________________________________
TABLE 7 ______________________________________ BSA (1.0%) BSA (1.0%)/Clupeine (0.1%) % oil % FE % FLS % FE % FLS ______________________________________ 0 664 31 720 47 1.0 100 5 -- -- 5.0 172 4 712 51 10.0 128 4 704 49 20.0 176 7 640 60 25.0 -- -- 504 64 ______________________________________
TABLE 8
______________________________________
Final Mix
Frappe Density (g/ml)
Protein Quantity (g)
Density (g/ml)
(Before graining)
______________________________________
Egg Albumen
15 0.65 1.25
Egg Albumen
6 0.68 1.23
Clupeine 1.5
Egg Albumen
15 0.65 0.97
Egg Albumen
7.5 0.71 1.38
Egg Albumen
7.5 0.58 0.97
M.P.I. 0.75
______________________________________
TABLE 9
______________________________________
Mix Baked
Density Density
Protein Quantity (g)
(g/100 ml) (g/100 ml)
______________________________________
Egg Albumen 18 23.5 12.0
Egg Albumen 9.0 25.6 14.2
Egg Albumen 8.1 20.2 10.1
Lysozyme 0.9
Egg Albumen 8.1 19.8 9.1
Clupeine 0.9
Egg Albumen 18 19.1 9.2
Egg Albumen 9.0 68.7 15.7
Egg Albumen 9.0 52.0 9.2
M.P.I. 0.9
Egg Albumen 18.0 NO FOAM AFTER
(+ 1% Fat) NORMAL WHIPPING
TIME (6 min.)
Egg Albumen 9.0 69.2 13.6
M.P.I. (+ 1% Fat)
0.9
Egg Albumen 18.0 47.5 17.2
(+ 3% cocoa
powder)
Egg Albumen 9.0 66.0 12.6
M.P.I. (+ 3%
0.9
cocoa powder)
______________________________________
TABLE 10
______________________________________
The effects of clupeine and pH on the gelation
of BSA and Plasma (95° C., 20 min).
pH
SYSTEM 4.0 5.0 6.0 7.0 8.0 9.0 10.0
______________________________________
2% BSA X X X X X
2% BSA + 0.2%
X
Clupeine
2% Plasma X X X X X X
2% Plasma + 0.2%
X X
Clupeine
______________________________________
GEL FORMED
X GEL NOT FORMED
TABLE 11
______________________________________
Effect of Clupeine Concentration on Gelation
of BSA (pH 8, 95° C., 20 min.)
System Gelation
______________________________________
3% BSA X
3% BSA + 0.1% Clupeine
X
3% BSA + 0.2% Clupeine
X
3% BSA + 0.3% Clupeine
1% BSA + 0.5% Clupeine
X
1% BSA + 0.1% Clupeine
______________________________________
TABLE 12
______________________________________
Gelation of Plasma (pH 8, 95° C., 20 mins)
Plasma Plasma + Clupeine
Conc.sup.n (%)
Plasma alone
10:1 Ratio
______________________________________
4
4 (Dialysed) X --
3 X
2 X
1.5 X
1.0 X X
______________________________________
-- NOT TESTED
TABLE 13
______________________________________
Effect of Clupeine on the gel strength of plasma gels
%
Increase in
Sucrose gel strength
Plasma Temp. Clupeine Conc. %
Break with
Conc. %
°C.
Conc. % (w/v) point (g)
Clupeine
______________________________________
7.5 90 0 0 124
7.5 90 0.7 0 144 16
5.0 90 0 0 50
5.0 90 0.5 0 51 2
7.5 80 0 0 136
7.5 80 0.7 0 160 17
7.5 90 0 20 118
7.5 90 0.7 20 132 12
5.0 90 0 20 23
5.0 90 0.5 20 33 43
______________________________________
TABLE 14
______________________________________
System Gelation
______________________________________
5% Bipro X
5% Bipro + 0.1% Clupeine
X
5% Bipro + 0.2% Clupeine
X
5% Bipro + 0.3% Clupeine
X
5% Bipro + 0.4% Clupeine
5% Bipro + 0.5% Clupeine
X
3% Bipro + 0.1% Clupeine
3% Bipro + 0.2% Clupeine
3% Bipro + 0.3% Clupeine
X
______________________________________
Bipro is a whey protein isolate
TABLE 15
______________________________________
Effect of Clupeine on Gelation of Egg Albumen
(pH 8, 95° C.). 20 min.
System Gelation
______________________________________
5% Egg Albumen
4% Egg Albumen
3% Egg Albumen X
2% Egg Albumen X
5% E.A. + 0.5% Clupeine
4% E.A. + 0.4% Clupeine
3% E.A. + 0.3% Clupeine
2% E.A. + 0.2% Clupeine
1% E.A. + 0.1% Clupeine
X
______________________________________
TABLE 16
__________________________________________________________________________
Separation of protein-oil water emulsions after storage for 1 week at
ambient temperature
Egg White Egg White + Lysozyme
Plasma Plasma + Lysozyme
% % % % % % % % % % % %
Oil
Emulsion
Water
Oil
Emulsion
Water
Oil
Emulsion
Water
Oil
Emulsion
Water
__________________________________________________________________________
3 66 31 -- 82 18 2 67 31 -- 88 12
__________________________________________________________________________
Claims (14)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/625,646 US4572837A (en) | 1984-06-28 | 1984-06-28 | Protein product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/625,646 US4572837A (en) | 1984-06-28 | 1984-06-28 | Protein product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US4572837A true US4572837A (en) | 1986-02-25 |
Family
ID=24506989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US06/625,646 Expired - Fee Related US4572837A (en) | 1984-06-28 | 1984-06-28 | Protein product |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US4572837A (en) |
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989005098A1 (en) * | 1987-12-02 | 1989-06-15 | Singer Norman S | Protein product |
| US5096730A (en) | 1986-06-20 | 1992-03-17 | John Labatt Limited/John Labatt Limitee | Reduced fat sour cream |
| US5096731A (en) | 1989-06-16 | 1992-03-17 | John Labatt Limited/John Labatt Limitee | Reduced fat yogurt |
| US5098728A (en) | 1989-06-16 | 1992-03-24 | John Labatt Limited/John Labbat Limitee | Reduced fat food product |
| US5139811A (en) | 1984-05-04 | 1992-08-18 | John Labatt Limited | Viscous salad dressing |
| US5580491A (en) * | 1993-07-13 | 1996-12-03 | Cornell Research Foundation, Inc. | Foamable whey protein composition |
| US5681505A (en) * | 1993-07-13 | 1997-10-28 | Cornell Research Foundation, Inc. | Stabilized foamable whey protein composition |
| US6117473A (en) * | 1999-06-21 | 2000-09-12 | Kraft Foods, Inc. | Refrigerator-stable, non-dairy foam |
| US6479083B1 (en) | 2000-11-15 | 2002-11-12 | Kraft Food Holdings, Inc. | Process for making partially digested soy protein-containing dressing |
| US6514681B2 (en) | 2001-05-24 | 2003-02-04 | Eastman Kodak Company | High bromide tabular grain emulsions precipitated in a novel dispersing medium |
| US20030124647A1 (en) * | 2001-11-06 | 2003-07-03 | Novozymes North America, Inc. | Modified whey protein compositions having improved foaming properties |
| US20050163904A1 (en) * | 2004-01-22 | 2005-07-28 | Durafizz, Llc | Foam forming particles and methods |
| US20080206426A1 (en) * | 2005-08-31 | 2008-08-28 | Nestec S.A. | Low-Fat Confectionery Product |
| US8557296B2 (en) * | 2009-09-24 | 2013-10-15 | Rajan V. Vembu | Compositions and methods for the prevention and treatment of metabolic diseases |
| US20160175794A1 (en) * | 2013-07-26 | 2016-06-23 | Qmilch Ip Gmbh | Protein foam |
Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2183515A (en) * | 1939-06-14 | 1939-12-12 | Ind Patents Corp | Reconstitution of dried egg material |
| FR2061019A5 (en) * | 1969-09-05 | 1971-06-18 | Unilever Nv | |
| GB1334397A (en) * | 1971-01-26 | 1973-10-17 | Wolfen Filmfab Veb | Gelatin composition |
| US3870811A (en) * | 1971-04-16 | 1975-03-11 | Gervais Danone Ag | Processes for the production of protein-rich foodstuffs from natural protein-containing foods that are subject to syneresis |
| US3899609A (en) * | 1968-06-05 | 1975-08-12 | Neal A Lonneker | Process for chemically bonding animal protein to peeled kernels of cereal grains |
| US3900576A (en) * | 1972-09-18 | 1975-08-19 | Miles Lab | Meat emulsion extender process |
| US3939284A (en) * | 1975-01-29 | 1976-02-17 | Standard Oil Company | Process for the production of meat, poultry and fish analogs and the products thereof |
| US4082857A (en) * | 1975-10-21 | 1978-04-04 | P. Leiner & Sons Limited | Gelatin composition |
| US4178391A (en) * | 1976-06-01 | 1979-12-11 | Standard Oil Company A Corporation Of Indiana | Process for improving the functional properties of protein material |
| US4228198A (en) * | 1975-07-04 | 1980-10-14 | Tate & Lyle Limited | Sweetening compositions containing arabinogalactan |
| US4234609A (en) * | 1978-08-28 | 1980-11-18 | Ralston Purina Company | Method of forming food product from mollusks and product thereof |
| US4238480A (en) * | 1978-05-19 | 1980-12-09 | Sawyer Philip Nicholas | Method for preparing an improved hemostatic agent and method of employing the same |
| US4265917A (en) * | 1977-05-04 | 1981-05-05 | Rhone-Poulenc Industries | Binder compositions for texturized proteins and their use in the preparation of foodstuff |
| US4292336A (en) * | 1979-02-06 | 1981-09-29 | Talres Development (N.A.) N.V. | Sweetening compositions containing peptide sweeteners and a method for their manufacture |
| US4409248A (en) * | 1981-08-10 | 1983-10-11 | A. E. Staley Manufacturing Company | Heat-gelling and foam-stabilizing enzymatically modified vegetable isolates |
| US4474694A (en) * | 1982-11-08 | 1984-10-02 | Ralston Purina Company | Modified protein adhesive binder and method of producing |
-
1984
- 1984-06-28 US US06/625,646 patent/US4572837A/en not_active Expired - Fee Related
Patent Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2183515A (en) * | 1939-06-14 | 1939-12-12 | Ind Patents Corp | Reconstitution of dried egg material |
| US3899609A (en) * | 1968-06-05 | 1975-08-12 | Neal A Lonneker | Process for chemically bonding animal protein to peeled kernels of cereal grains |
| FR2061019A5 (en) * | 1969-09-05 | 1971-06-18 | Unilever Nv | |
| GB1334397A (en) * | 1971-01-26 | 1973-10-17 | Wolfen Filmfab Veb | Gelatin composition |
| US3870811A (en) * | 1971-04-16 | 1975-03-11 | Gervais Danone Ag | Processes for the production of protein-rich foodstuffs from natural protein-containing foods that are subject to syneresis |
| US3900576A (en) * | 1972-09-18 | 1975-08-19 | Miles Lab | Meat emulsion extender process |
| US3939284A (en) * | 1975-01-29 | 1976-02-17 | Standard Oil Company | Process for the production of meat, poultry and fish analogs and the products thereof |
| US4228198A (en) * | 1975-07-04 | 1980-10-14 | Tate & Lyle Limited | Sweetening compositions containing arabinogalactan |
| US4082857A (en) * | 1975-10-21 | 1978-04-04 | P. Leiner & Sons Limited | Gelatin composition |
| US4178391A (en) * | 1976-06-01 | 1979-12-11 | Standard Oil Company A Corporation Of Indiana | Process for improving the functional properties of protein material |
| US4265917A (en) * | 1977-05-04 | 1981-05-05 | Rhone-Poulenc Industries | Binder compositions for texturized proteins and their use in the preparation of foodstuff |
| US4238480A (en) * | 1978-05-19 | 1980-12-09 | Sawyer Philip Nicholas | Method for preparing an improved hemostatic agent and method of employing the same |
| US4234609A (en) * | 1978-08-28 | 1980-11-18 | Ralston Purina Company | Method of forming food product from mollusks and product thereof |
| US4292336A (en) * | 1979-02-06 | 1981-09-29 | Talres Development (N.A.) N.V. | Sweetening compositions containing peptide sweeteners and a method for their manufacture |
| US4409248A (en) * | 1981-08-10 | 1983-10-11 | A. E. Staley Manufacturing Company | Heat-gelling and foam-stabilizing enzymatically modified vegetable isolates |
| US4474694A (en) * | 1982-11-08 | 1984-10-02 | Ralston Purina Company | Modified protein adhesive binder and method of producing |
Non-Patent Citations (10)
| Title |
|---|
| 1373 Journal of the Science of Food and Agriculture, vol. 35, (1984) Jun., No. 6, Oxford, Great Britain, pp. 701 711. * |
| 1373 Journal of the Science of Food and Agriculture, vol. 35, (1984) Jun., No. 6, Oxford, Great Britain, pp. 701-711. |
| ALBIHNS (H. Algihns Patentbyra AB, letter). * |
| D. J. Cram, et al.: "Organic Chemistry", 1959, p. 589, McGraw-Hill Book Company, Inc., London, GB. |
| D. J. Cram, et al.: Organic Chemistry , 1959, p. 589, McGraw Hill Book Company, Inc., London, GB. * |
| Egg Albumen Proteins Interactions in an Angel Food Cake System; Teiko M. Johnson and Mary E. Zabik, vol. 46 (1981) Journal of Food Science; p. 1231, col. 1; p. 1234 col. 2; pp. 1235; 1236, col. 1. * |
| Journal of Agricultural and Food Chemistry, vol. 31, No. 5, Sep./Oct. 1983, pp. 972 978, American Chemical Society, Washington, US; N. L. Mattarella et al.: Physico chemical and Functional Properties of Positively Charged Derivatives of Bovine Beta Lactoglobulin ; pp. 972 976. * |
| Journal of Agricultural and Food Chemistry, vol. 31, No. 5, Sep./Oct. 1983, pp. 972-978, American Chemical Society, Washington, US; N. L. Mattarella et al.: "Physico-chemical and Functional Properties of Positively Charged Derivatives of Bovine Beta-Lactoglobulin"; pp. 972-976. |
| Schweizerisches Lebensmittelbuch, Schweiz. Verein analytischer Chemiker. * |
| The Merck Index, Tenth Edition, 1983; An Encyclopedia of Chemicals, Drugs and Biologicals. * |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139811A (en) | 1984-05-04 | 1992-08-18 | John Labatt Limited | Viscous salad dressing |
| US5096730A (en) | 1986-06-20 | 1992-03-17 | John Labatt Limited/John Labatt Limitee | Reduced fat sour cream |
| WO1989005098A1 (en) * | 1987-12-02 | 1989-06-15 | Singer Norman S | Protein product |
| WO1989005099A1 (en) * | 1987-12-02 | 1989-06-15 | Singer Norman S | Protein product |
| US5096731A (en) | 1989-06-16 | 1992-03-17 | John Labatt Limited/John Labatt Limitee | Reduced fat yogurt |
| US5098728A (en) | 1989-06-16 | 1992-03-24 | John Labatt Limited/John Labbat Limitee | Reduced fat food product |
| US5580491A (en) * | 1993-07-13 | 1996-12-03 | Cornell Research Foundation, Inc. | Foamable whey protein composition |
| US5681505A (en) * | 1993-07-13 | 1997-10-28 | Cornell Research Foundation, Inc. | Stabilized foamable whey protein composition |
| US6117473A (en) * | 1999-06-21 | 2000-09-12 | Kraft Foods, Inc. | Refrigerator-stable, non-dairy foam |
| US6479083B1 (en) | 2000-11-15 | 2002-11-12 | Kraft Food Holdings, Inc. | Process for making partially digested soy protein-containing dressing |
| US6514681B2 (en) | 2001-05-24 | 2003-02-04 | Eastman Kodak Company | High bromide tabular grain emulsions precipitated in a novel dispersing medium |
| US20030124647A1 (en) * | 2001-11-06 | 2003-07-03 | Novozymes North America, Inc. | Modified whey protein compositions having improved foaming properties |
| US7897186B2 (en) | 2001-11-06 | 2011-03-01 | Novozymes North America, Inc. | Modified whey protein compositions having improved foaming properties |
| US20050163904A1 (en) * | 2004-01-22 | 2005-07-28 | Durafizz, Llc | Foam forming particles and methods |
| US20080206426A1 (en) * | 2005-08-31 | 2008-08-28 | Nestec S.A. | Low-Fat Confectionery Product |
| US8557296B2 (en) * | 2009-09-24 | 2013-10-15 | Rajan V. Vembu | Compositions and methods for the prevention and treatment of metabolic diseases |
| US20140227409A1 (en) * | 2009-09-24 | 2014-08-14 | Rajan V. Vembu | Compositions and methods for the prevention and treatment of metabolic diseases |
| US20160175794A1 (en) * | 2013-07-26 | 2016-06-23 | Qmilch Ip Gmbh | Protein foam |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4572837A (en) | Protein product | |
| EP0327120B1 (en) | Process for producing rolled-in type emulsified fat and oil composition | |
| EP0402090B1 (en) | Edible oil-in water emulsion | |
| US5690986A (en) | Oil-in-water type emulsion and process for producing the same | |
| US4861610A (en) | Process for preparing emulsified fat composition containing cheese | |
| EP0037447B1 (en) | Acid-resisting whipping cream powder and process for producing the same | |
| EP0441494A1 (en) | Low-calorie fat substitute | |
| IE41943B1 (en) | Stabilised emulsions comprising phospholip-protein | |
| BR0012257B1 (en) | ACID EMULSIFIED OIL-IN-WATER COMPOSITION | |
| US4360537A (en) | Lipoprotein emulsions for food use and methods for preparing the same | |
| US3712865A (en) | Edible oil emulsions | |
| JPS63185350A (en) | Emulsification of fats of oils in aqueous phase consisting essentially of soy sauce | |
| US5194282A (en) | Food products having a reduced fat content | |
| GB2134117A (en) | Protein composition | |
| US4325979A (en) | Powdered compositions for cream toppings | |
| JP2003134998A (en) | Oil-in-water emulsion for kneading pudding | |
| EP0163787A1 (en) | Protein product | |
| JP3113042B2 (en) | Production method of oil-in-water emulsion | |
| Slack et al. | Foaming and emulsifying characteristics of fractionated whey protein | |
| Garti | Food emulsifiers and stabilizers | |
| JP3112552B2 (en) | Oil-in-water emulsion, powder and whipped cream | |
| JPH10313806A (en) | Oil composition for kneading custard cream | |
| WO2001058272A1 (en) | Emulsified foods with high oil content and low moisture content and process for producing the same | |
| JPH093479A (en) | Oil and fat emulsified composition and method for producing the same | |
| WO2000011973A1 (en) | Spray-dried emulsified topping base |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: BRITISH FOOD MANUFACTURING INDUSTRIES RESEARCH ASS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:POOLE, STEPHEN;WEST, STUART I.;WALTERS, CLIFFORD L.;REEL/FRAME:004280/0381 Effective date: 19840619 |
|
| FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| REMI | Maintenance fee reminder mailed | ||
| REMI | Maintenance fee reminder mailed | ||
| LAPS | Lapse for failure to pay maintenance fees | ||
| FP | Lapsed due to failure to pay maintenance fee |
Effective date: 19940227 |
|
| STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |